Jim Ackland PHD
Regulatory Affairs Consultant
Jim has over 30 years experience in the manufacture, quality control, development and international regulatory requirements for biopharmaceutical products. He has provided regulatory and product development advice and assistance to large and small companies. Prior to establishing Global Bioscience Solutions, Jim was employed at CSL Limited as Head of Regulatory Affairs.
Prof. John Hayball
Immunologist at University of South Australia, South Australia, Australia
Heads the Experimental Therapeutics Laboratory (ETL), Sansom Institute for Health Research at the University of South Australia. Associate Professor Hayball has an interest in understanding the fundamental mechanisms involved in controlling the mammalian immune response, particularly those involved in the development of an early innate immune response. He is using this information in rational approaches to develop new therapeutics for the prevention and treatment of diseases such as cancer, infection and wound healing. Sementis is funding 8 scientists working in the ETL. Sementis (with Ass. Prof. Hayball’s oversight) conducts all preclinical immunological research and testing the efficacy of its new vaccines at ETL.
Prof. Andreas Suhrbier
Immunologist at QIMR Berghofer Medical Research Institute, Queensland, Australia
Prof Suhrbier is a world leader in infectious diseases particularly Chikungunya. He is member of Global Virus Networks and Chikungunya Working Party. He has developed an internationally accepted mouse model for studying Chikungunya infection. Using his model, he has tested our Chikungunya vaccine and has shown that Sementis vaccine can protect mice from a virulent Chikungunya challenge.